BICATERO

This brand name is authorized in Nigeria. It is also authorized in Ecuador.

Active ingredients

The drug BICATERO contains one active pharmaceutical ingredient (API):

1	Bicalutamide UNII A0Z3NAU9DP - BICALUTAMIDE
	Bicalutamide is a non-steroidal antiandrogen, devoid of other endocrine activity. It binds to androgen receptors without activating gene expression, and thus inhibits the androgen stimulus. Regression of prostatic tumours results from this inhibition.
	Read more about Bicalutamide

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7380	Tablet	BICATERO 50 BICALUTAMIDE TABLETS 50MG TAB 50 mg 1 X 30	124 RNW-PP-286529 BICATERO 50 BICALUTAMIDE TABLETS 50MG BICALUTAMIDE 50MG LACTOSE MONOHYDRATE 61.000MG B4-7380 Drugs Imported Products 130 Prescription Only Medicine (POM) 6/20/2023 HETERO LABS NIGERIA LIMITED, NO. 8B, WOLE OGUNJIMI STREET, AGBAOKU ESTATE, OFF OPEBI ROAD, IKEJA, LAGOS. 8060878739 heteronig@yahoo.com M/S. HETERO LABS LIMITED, UNIT VI, SY.NO.410-411, TSIIC FORMULATION SEZ, POLEPALLY VILLAGE, JADCHERLA MANDAL, MAHABOOBNAGAR DISTRICT, TELANGANA STATE, INDIA., India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L02BB03	Bicalutamide	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BB Anti-androgens
Discover more medicines within L02BB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	5511-MEE-0920
NG	Registered Drug Product Database	B4-7380